Sign in

CIK 0001512762 · Accelerated filer<br>Smaller reporting company

Coherus Oncology, Inc.

Sign in to watch
Ticker
CHRS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
273615821
Phone
(650) 649-3530
Business address
C/O DENNIS M. LANFEAR, 333 TWIN DOLPHIN DR, SUITE 600, REDWOOD CITY, CA, 94065
Former names
Coherus BioSciences, Inc., BioGenerics, Inc.
  1. 4 Gift Director gave 99,988 shares (gift)
  2. SC 13G/A Stake Amended Statement of Ownership
  3. SC 13G/A Stake Amended Statement of Ownership
  4. SC 13G/A Stake Amended Statement of Ownership
  5. 4 Option exercise Director acquired 59,988 shares (option exercise)
  6. 8-K Event Material agreement · Regulation FD disclosure
  7. SC 13G/A Stake Amended Statement of Ownership
  8. 4 Shares withheld for taxes President & CEO gave up 11,218 shares (to pay taxes)
  9. 4 Shares withheld for taxes Chief Commercial Officer gave up 4,854 shares (to pay taxes)
  10. 4 Shares withheld for taxes See Remarks gave up 1,707 shares (to pay taxes)
  11. SC 13G/A Stake Amended Statement of Ownership
  12. 8-K Event Material agreement · Regulation FD disclosure
  13. 8-K Event Results of operations
  14. 8-K Event Other events
  15. 4 Shares withheld for taxes See Remarks gave up 1,707 shares (to pay taxes)
  16. 4 Shares withheld for taxes President & CEO gave up 11,781 shares (to pay taxes)
  17. 4 Shares withheld for taxes Chief Commercial Officer gave up 2,275 shares (to pay taxes)
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Shares withheld for taxes Chief Financial Officer gave up 18,440 shares (to pay taxes)

Page 9 of 47 · 923 filings